🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be an open label study of secukinumab for the treatment of ...
Status
Completed
Location
Hospital at the University of Pennsylvania
Start Date
2022-02-07
Trial ID
NCT04535999
Treatments Being Tested
This study will assess the ability of AIN457 to attenuate the increase in a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-01
Trial ID
NCT00920933
Treatments Being Tested
This was a retrospective observational study that relied on data extracted ...
Status
Completed
Location
Novartis
Start Date
2021-08-03
Trial ID
NCT06666114
This study will assess the efficacy and safety of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-09-29
Trial ID
NCT02267135
Treatments Being Tested
The purpose of this study was to demonstrate efficacy, including effects on...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-08-30
Trial ID
NCT02771210
Treatments Being Tested
The purpose of the study was to evaluate the efficacy and safety of secukin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-06-30
Trial ID
NCT03136861
Treatments Being Tested
The COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a m...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-15
Trial ID
NCT05080218
This study will assess the safety and efficacy of AIN457 in patients with m...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2008-08
Trial ID
NCT00584740
The purpose of this pivotal trial is to evaluate subcutaneous (SQ) AIN457 a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-10
Trial ID
NCT00995709
The primary objective of this study was to evaluate safety and tolerability...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02911857
Treatments Being Tested